Wiseguyreports.Com Adds “Geriatric Medicines Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2026” To Its Research Database
Global Geriatric Medicines Market is expected to grow at a CAGR of 9.3% during the forecast period. Increasing occurrence of diabetes and cardiovascular diseases amongst old people, increase in government support, improving healthcare infrastructure in number of upcoming economies are some of the key factors favouring the market growth. However, factors such as lack of awareness need of patient participation in clinical trials and side effects of medicines are hindering the market growth. In addition, increasing demand from emerging economies holds huge growth opportunities for market growth.
Geriatrics is a division of medicines connected to the remedial, clinical, social, and preventive aspects of ill health among old people over 65 years. The majority of the geriatrics is not capable to take their medication correctly at the intended time due to difficult in psychological and medical issues. The geriatric inhabitants need special attention and care for the rapid recovery of disorder or disease.
By Therapeutic Category, antihypertensive segment is projected to have significant share during the forecast period. Antihypertensive are a group of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy prevents problems of high blood pressure such as stroke and myocardial infarction. Restless lifestyle of the urban populations and growing life expectancy are favouring the growth of antihypertensive medicines for geriatrics. By Geography, North America region is projected to grow at a significant rate due to high prevalence of chronic diseases, favourable administration initiative for the old people and presence of some pioneering companies of this market.
Some of the key players in geriatrics medicine market includes Abbott Laboratories, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc., Merck & Company Inc, Novartis AG, Pfizer and Inc., Sanofi S.A.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3249020-drugs-of-abuse-testing-global-market-outlook-2017-2026
Therapeutic Categories Covered:
• Antidepressant & Antipsychotic
• Proton Pump Inhibitor (PPI)
• Other Therapeutic Categories
• Other Conditions
The report of the Geriatric Medicines market provides competitive strategies over various regions on a global note, where key players tend to maximize profits through partnerships into several regions. The regional report of the Geriatric Medicines market aims at assessing the market size and future growth potential across the mentioned regions. The report makers cover the regions such as North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa with the prediction of future market expansion. The study of the Geriatric Medicines market is done broadly following all these regions to embrace outlook, latest trends, and prospects in the given review period of 2019-2026.
The global Geriatric Medicines market has been studied for the forecast period by employing Porter’s Five Force Model for the review period of 2019 to 2026. In addition, a detailed SWOT analysis has been conducted for an accurate understanding of the various factors influencing the market.
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)